| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |